Folitrax 25 Tablet 4

Folitrax 25 Tablet 4 is strictly contraindicated during pregnancy due to its potential to cause serious harm to the developing foetus. If you are pregnant or planning to conceive, inform your doctor immediately. Use effective contraception during treatment to avoid pregnancy.

This medication is also not recommended for breastfeeding mothers, as it may pass into breast milk and harm the infant. Consult your doctor to discuss alternatives or the need to discontinue breastfeeding during treatment.

Consuming alcohol while using Folitrax 25 Tablet 4 can amplify its potential side effects, particularly those affecting the liver. It is crucial to discuss your alcohol consumption habits with your doctor before starting this treatment.

Patients with existing liver conditions should exercise caution while using Folitrax 25 Tablet 4, as it may exacerbate liver problems. Regular monitoring of liver function tests is often required during treatment to ensure safety.

Folitrax 25 Tablet 4 may also affect kidney function, particularly in individuals with pre-existing kidney issues. Discuss your kidney health with your doctor, who may recommend dosage adjustments or additional monitoring during treatment.

This medicine can cause side effects such as dizziness, fatigue, or blurred vision, which may impair your ability to drive or operate machinery safely. Ensure you understand how Methofast affects you before engaging in such activities.

If you have a known allergy to methotrexate or any other ingredient in Folitrax 25 Tablet 4, avoid using this medication. Notify your doctor immediately if you experience symptoms like rash, itching, swelling, or difficulty breathing.

Folitrax 25 Tablet 4 is intended for adult use. The safety and effectiveness of this medicine in children have not been established, so it should not be given to children under 18 without medical supervision.

Older adults, particularly those above 70 years of age, are more susceptible to the side effects of Folitrax 25 Tablet 4. Caution and close monitoring by a healthcare professional are recommended for this age group.